Monday, June 15, 2026

“Clicked install, crypto wallet hacked”…warning issued over ‘Claude’ impersonation site

A phishing site masquerading as the 'Claude' AI service has emerged, tricking users into downloading malicious code via Google search results.

North Korean Hackers Use AI Deepfakes to Infiltrate 320 Companies, CrowdStrike Reveals

A North Korean hacker group used generative AI to infiltrate 320 companies, automating attacks and employing sophisticated malware tactics.

North Korea Launches Multiple Short-Range Missiles in Provocative Show of Force

North Korea fired multiple short-range ballistic missiles into the East Sea, marking its second military provocation of the year.

Tag: Onconic Therapeutics

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.